Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer

Documenti analoghi

• Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression
  di: Jieqi Zhou, et al.
  Pubblicazione: (2022-05-01)
• The miR-625-3p/AXL axis induces non-T790M acquired resistance to EGFR-TKI via activation of the TGF-β/Smad pathway and EMT in EGFR-mutant non-small cell lung cancer
  di: Du, Wenwen, et al.
  Pubblicazione: (2020)
• Anlotinib can overcome acquired resistance to EGFR‐TKIs via FGFR1 signaling in non‐small cell lung cancer without harboring EGFR T790M mutation
  di: Lian, Zengzhi, et al.
  Pubblicazione: (2020)
• The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer
  di: Zhang, Yang, et al.
  Pubblicazione: (2019)
• CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer
  di: Zhu, Jianjie, et al.
  Pubblicazione: (2021)